Syndax Pharmaceuticals (SNDX) Presents Positive Data from Pi

Syndax Pharmaceuticals (SNDX) Presents Positive Data from Pivotal AUGMENT-101 Trial of Revumenib

Syndax Pharmaceuticals (SNDX) Presents Positive Data from Pivotal AUGMENT-101 Trial of Revumenib

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

San Diego , California , United States , Revumenib Monotherapy , Michaela Metzger , Ibrahim Aldoss , Division Of Leukemia , Drug Administration , Syndax Pharmaceuticals Nasdaq , American Society Of Hematology , Syndax Pharmaceuticals , American Society , Annual Meeting , Acute Leukemia , Topline Efficacy , Safety Results , Chief Executive Officer , New Drug Application , Attending Physician , Associate Professor , Hematopoietic Cell Transplantation , Principal Investigator ,